Detalhe da pesquisa
1.
RNA aggregates harness the danger response for potent cancer immunotherapy.
Cell;
187(10): 2521-2535.e21, 2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38697107
2.
Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy.
Nano Lett;
18(10): 6195-6206, 2018 10 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30259750
3.
Evaluation of Immunomodulatory Effects of Mesenchymal Stem Cells Soluble Factors on miR-155 and miR-23b Expression in Mice Dendritic Cells.
Immunol Invest;
44(5): 427-37, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26107743
4.
mRNA challenge predicts brain cancer immunogenicity and response to checkpoint inhibitors.
bioRxiv;
2023 Mar 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36993158
5.
mRNA aggregates harness danger response for potent cancer immunotherapy.
medRxiv;
2023 Mar 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36993772
6.
Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy.
Front Oncol;
11: 691246, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34150663
7.
Optimizing T Cell-Based Therapy for Glioblastoma.
Front Immunol;
12: 705580, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34421912
8.
Fc Receptor-Like Gene Expression in Renal Transplantation Patients.
Galen Med J;
9: e1730, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34466580
9.
Ultrasound wave assisted removal of Ceftriaxone sodium in aqueous media with novel nano composite g-C3N4/MWCNT/Bi2WO6 based on CCD-RSM model.
Ultrason Sonochem;
68: 104460, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30712851
10.
Comparing Standard Performance and Outcome Measures in Hospitalized Pituitary Tumor Patients with Secretory versus Nonsecretory Tumors.
World Neurosurg;
135: e510-e519, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31863896
11.
Adult immuno-oncology: using past failures to inform the future.
Neuro Oncol;
22(9): 1249-1261, 2020 09 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32391559
12.
Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.
Cancer Res;
80(3): 499-509, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31723000
13.
The role of CMV in glioblastoma and implications for immunotherapeutic strategies.
Oncoimmunology;
8(1): e1514921, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30546954
14.
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
J Immunother Cancer;
7(1): 321, 2019 11 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31753028
15.
Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.
Transplantation;
103(6): 1121-1130, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30801518
16.
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
Neuro Oncol;
21(6): 730-741, 2019 06 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30668768
17.
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.
Nat Commun;
10(1): 4016, 2019 09 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31488817
18.
Temozolomide for immunomodulation in the treatment of glioblastoma.
Neuro Oncol;
20(12): 1566-1572, 2018 11 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29733389
19.
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.
Front Mol Neurosci;
11: 82, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29643764